Diagnosis and management of benign prostatic hyperplasia in primary care

Authors

  • Simon Tanguay Head, Division of Urologic Oncology, McGill University Health Centre, Associate Professor Department of Surgery (Urology), McGill University, Montréal, QC
  • Murray Awde Adjunct Professor of Family Medicine, University of Western Ontario, London, ON
  • Gerald Brock Professor, Division of Urology, Department of Surgery, University of Western Ontario, London, ON
  • Richard Casey Medical Director, The Male Health Centres, Oakville, ON
  • Joseph Kozak Family Physician Department, Toronto Western Hospital, Toronto, ON
  • Jay Lee Clinical Lecturer, Department of Surgery, Division of Urology, University of Calgary, Calgary, AB
  • J. Curtis Nickel Professor, Department of Urology, Queen’s University, Kingston, ON
  • Fred Saad Professor of Surgery and Urology, University of Montréal, Montréal, QC

DOI:

https://doi.org/10.5489/cuaj.1116

Abstract

Benign prostatic hyperplasia (BPH), and its clinical manifestation as lower urinary
tract symptoms (LUTS), is a major health concern for aging men. There have
been significant advances in the diagnosis and treatment of BPH in recent
years. There has been a renewed interest in medical therapies and less invasive
surgical techniques. As a consequence, the treatment needs of men with
mild to moderate LUTS without evidence of prostate cancer can now be accomplished
in a primary care setting. There are differences in the way urologists
and primary care physicians approach the evaluation and management of LUTS
due to BPH, which is not reflected in Canadian Urological Association (CUA)
and American Urological Association (AUA) guidelines. A “shared care” approach
involving urologists and primary care physicians represents a reasonable and
viable model for the care of men suffering from LUTS. The essence of the model
centres around educating and communicating effectively with the patient on
BPH. This article provides primary care physicians with an overview of the diagnostic
and management strategies outlined in recent CUA and AUA guidelines
so that they may be better positioned to effectively deal with this patient population.
It is now apparent that we must move away from the urologist as the
first-line physician, and allow primary care physicians to accept a new role in
the diagnosis and management of BPH.

Downloads

Download data is not yet available.

Author Biographies

Simon Tanguay, Head, Division of Urologic Oncology, McGill University Health Centre, Associate Professor Department of Surgery (Urology), McGill University, Montréal, QC

Murray Awde, Adjunct Professor of Family Medicine, University of Western Ontario, London, ON

Gerald Brock, Professor, Division of Urology, Department of Surgery, University of Western Ontario, London, ON

Richard Casey, Medical Director, The Male Health Centres, Oakville, ON

Joseph Kozak, Family Physician Department, Toronto Western Hospital, Toronto, ON

Jay Lee, Clinical Lecturer, Department of Surgery, Division of Urology, University of Calgary, Calgary, AB

J. Curtis Nickel, Professor, Department of Urology, Queen’s University, Kingston, ON

Fred Saad, Professor of Surgery and Urology, University of Montréal, Montréal, QC

Downloads

How to Cite

Tanguay, S., Awde, M., Brock, G., Casey, R., Kozak, J., Lee, J., Nickel, J. C., & Saad, F. (2013). Diagnosis and management of benign prostatic hyperplasia in primary care. Canadian Urological Association Journal, 3(3-S2), S92-S100. https://doi.org/10.5489/cuaj.1116